Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Goubin

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Oncogene|June 15, 1995
Identification of binding domains on the p21Cip1 cyclin-dependent kinase inhibitorF Goubin, B Ducommun
EMBO Reports|March 21, 2001
Human Cdc25 A inactivation in response to S phase inhibition and its role in preventing premature mitosisM Molinari, C Mercurio, J Dominguez, et al.
Molecular Biology of the Cell|April 1, 1996
Heterologous expression of the human cyclin-dependent kinase inhibitor p21Cip1 in the fission yeast, Schizosaccharomyces pombe reveals a role for PCNA in the chk1+ cell cycle checkpoint pathwayS Tournier, D Leroy, F Goubin, et al.
Bulletin Du Cancer|May 1, 1994
[Pharmacological control of P-glycoprotein expression]C Muller, J D Bailly, J P Jaffrezou, et al.
Biochemistry|July 11, 1995
Mechanism of inhibition of proliferating cell nuclear antigen-dependent DNA synthesis by the cyclin-dependent kinase inhibitor p21V N Podust, L M Podust, F Goubin, et al.
FEBS Letters|August 5, 1996
Interaction studies between the p21Cip1/Waf1 cyclin-dependent kinase inhibitor and proliferating cell nuclear antigen (PCNA) by surface plasmon resonanceM Knibiehler, F Goubin, N Escalas, et al.
International Journal of Cancer|March 1, 1994
Verapamil decreases P-glycoprotein expression in multidrug-resistant human leukemic cell linesC Muller, J D Bailly, F Goubin, et al.
The Journal of Biological Chemistry|May 16, 2000
Distinct Chk2 activation pathways are triggered by genistein and DNA-damaging agents in human melanoma cellsJ M Darbon, M Penary, N Escalas, et al.
Oncogene|March 14, 2000
Specific interaction between 14-3-3 isoforms and the human CDC25B phosphataseV Mils, V Baldin, F Goubin, et al.
Molecular Pharmacology|January 1, 1995
Evidence for transcriptional control of human mdr1 gene expression by verapamil in multidrug-resistant leukemic cellsC Muller, F Goubin, E Ferrandis, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Oncogene|June 15, 1995
Identification of binding domains on the p21Cip1 cyclin-dependent kinase inhibitorF Goubin, B Ducommun
EMBO Reports|March 21, 2001
Human Cdc25 A inactivation in response to S phase inhibition and its role in preventing premature mitosisM Molinari, C Mercurio, J Dominguez, et al.
Molecular Biology of the Cell|April 1, 1996
Heterologous expression of the human cyclin-dependent kinase inhibitor p21Cip1 in the fission yeast, Schizosaccharomyces pombe reveals a role for PCNA in the chk1+ cell cycle checkpoint pathwayS Tournier, D Leroy, F Goubin, et al.
Bulletin Du Cancer|May 1, 1994
[Pharmacological control of P-glycoprotein expression]C Muller, J D Bailly, J P Jaffrezou, et al.
Biochemistry|July 11, 1995
Mechanism of inhibition of proliferating cell nuclear antigen-dependent DNA synthesis by the cyclin-dependent kinase inhibitor p21V N Podust, L M Podust, F Goubin, et al.
FEBS Letters|August 5, 1996
Interaction studies between the p21Cip1/Waf1 cyclin-dependent kinase inhibitor and proliferating cell nuclear antigen (PCNA) by surface plasmon resonanceM Knibiehler, F Goubin, N Escalas, et al.
International Journal of Cancer|March 1, 1994
Verapamil decreases P-glycoprotein expression in multidrug-resistant human leukemic cell linesC Muller, J D Bailly, F Goubin, et al.
The Journal of Biological Chemistry|May 16, 2000
Distinct Chk2 activation pathways are triggered by genistein and DNA-damaging agents in human melanoma cellsJ M Darbon, M Penary, N Escalas, et al.
Oncogene|March 14, 2000
Specific interaction between 14-3-3 isoforms and the human CDC25B phosphataseV Mils, V Baldin, F Goubin, et al.
Molecular Pharmacology|January 1, 1995
Evidence for transcriptional control of human mdr1 gene expression by verapamil in multidrug-resistant leukemic cellsC Muller, F Goubin, E Ferrandis, et al.
Pageof 1